![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Orders Halt of Regulus’ Chronic Hepatitis C Trial
FDA Orders Halt of Regulus’ Chronic Hepatitis C Trial
A second report of jaundice during Regulus Therapeutics’ trial evaluating RG-101 for the treatment of chronic hepatitis C virus infection has prompted the FDA to place a clinical hold on the study.
The company said it does not expect the hold to affect the timelines for three ongoing studies assessing the candidate.
Upcoming Events
-
21Oct